secwatch.observer — SEC 8-K summary
======================================

Issuer:     DBV Technologies S.A. (DBVT)
CIK:        0001613780
Form:       8-K
Filed at:   2026-06-29T20:28:49+00:00
Accession:  0001193125-26-288533
Event type: regulatory
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DBV Technologies delays VIASKIN Peanut Patch BLA submission to Q3 2026 after FDA feedback
--------------------------------------------------------------------------------

- BLA submission for VIASKIN Peanut Patch in children aged 4-7 delayed to Q3 2026.
- FDA did not request additional data; feedback focused on CMC and biostatistical data formatting.
- Company taking additional time to incorporate FDA input; prior timeline not specified.
- Conference call scheduled June 29, 2026 at 5pm ET for investor update.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613780/000119312526288533/0001193125-26-288533-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613780/000119312526288533/d108693d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-288533

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer